Clinical Trials Directory

Trials / Completed

CompletedNCT06242444

An Erosion Study to Investigate the Efficacy of an Experimental Dentifrice to Remineralize Enamel

A Randomized, Examiner Blind, Crossover, in Situ Erosion Study To Investigate The Efficacy Of An Experimental Dentifrice In Remineralization Of Softened Enamel Compared To Placebo and Reference Dentifrices

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the ability of an experimental dentifrice containing 1150 parts per million (ppm) fluoride to remineralize acid-softened dental enamel and help prevent further demineralization compared to a 0 ppm fluoride placebo dentifrice and a marketed, fluoride-containing dentifrice (Reference Dentifrice).

Detailed description

This will be a randomized, controlled, single center, single-blind, 3 period, 3 treatment, cross-over, in situ design study. Previously demineralized bovine enamel specimens will be placed intra orally using a palatal appliance and the remineralizing performance of the experimental, reference and placebo dentifrices will be evaluated at 4 and 12 hours post toothbrushing, based on surface micro hardness measurements of the bovine enamel specimens. At each treatment visit, once the palatal the appliance is fitted in the mouth, a five minute equilibration period will ensue following which each participant will brush their teeth with their assigned product. Participants will remove the appliance for 30 minutes at 4 and 8.5 hours post brushing and will remove and store the appliance 13 hours post brushing (12 hours intraoral exposure). Sufficient participants will be screened to randomize approximately 33 participants to study treatment to ensure approximately 30 participants complete the study.

Conditions

Interventions

TypeNameDescription
DRUGExperimental DentifriceDentifrice containing 1150 ppm fluoride and 5% KNO3.
DRUGPlacebo Control DentifriceDentifrice containing 0 ppm fluoride and 5% KNO3.
DRUGReference DentifriceDentifrice containing 1100 ppm fluoride as SnF2.

Timeline

Start date
2024-02-26
Primary completion
2024-05-07
Completion
2024-05-07
First posted
2024-02-05
Last updated
2025-05-08
Results posted
2025-05-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06242444. Inclusion in this directory is not an endorsement.